Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 16, 2017 07:00 ET | Source: Syndax Pharmaceuticals, Inc.

Syndax to Announce Fourth Quarter and Year-end 2016 Financial Results and Host Conference Call and Webcast on March 2, 2017

WALTHAM, Mass., Feb. 16, 2017 (GLOBE NEWSWIRE) -- Syndax (Nasdaq:SNDX) announced today that it will release its fourth quarter 2016 financial results on Thursday, March 2, 2017, after the close of...
February 15, 2017 07:00 ET | Source: Amunix Operating Inc.

Amunix announces broad alliance with Genentech using XTEN(R) technology

MOUNTAIN VIEW, CA--(Marketwired - February 15, 2017) - Amunix Operating Inc. (Amunix), a biopharmaceutical company focused on the discovery and development of novel biologics, announced today that it...
February 14, 2017 10:07 ET | Source: Research and Markets

T-Cell Immunotherapy Market, 2030: Post the Early Success of Immune Checkpoint Inhibitors, T-Cell Immunotherapy has Emerged as Another Innovative and Potent Arm of this Market

Dublin, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "T-Cell Immunotherapy Market (2nd Edition), 2017-2030" report to their offering. ...
February 14, 2017 10:02 ET | Source: Research and Markets

Rheumatoid Arthritis: Beyond TNF Inhibitors, 2026

Dublin, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Rheumatoid Arthritis: Beyond TNF Inhibitors, 2016-2026" report to their offering. ...
February 14, 2017 02:00 ET | Source: Vernalis PLC

Vernalis achieves a $3 million milestone payment from Corvus Pharmaceuticals Inc

WINNERSH, UNITED KINGDOM--(Marketwired - Feb 14, 2017) - Vernalis plc (LSE: VER) is pleased to announce the achievement of a clinical milestone from its collaboration with Corvus Pharmaceuticals...
February 10, 2017 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Reports Financial Results for Second Quarter of Fiscal Year 2017

DUBLIN, Ireland, Feb. 10, 2017 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET) today announced its financial results for the three and six month periods ended December 31, 2016.Recent...
February 09, 2017 07:00 ET | Source: Syndax Pharmaceuticals, Inc.

Syndax Appoints Richard P. Shea as Chief Financial Officer

WALTHAM, Mass., Feb. 09, 2017 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals, Inc. (“Syndax,” the “Company” or “we”) (Nasdaq:SNDX), a clinical stage biopharmaceutical company focused on developing...
February 06, 2017 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Reports Positive Outcome from the Data Safety Monitoring Board on the Two NeuVax™ (nelipepimut-S) Clinical Trials in Combination with Trastuzumab

Both combination trials are deemed not futile and Data Safety Monitoring Board recommends that both trials continueInterim efficacy analysis for the low-to-intermediate (HER2 1+/2+) trial now expected...
February 06, 2017 01:05 ET | Source: Zion Market Research

Global Melanoma Drugs Market will reach USD 4.71 Billion by 2022: Zion Market Research

Sarasota, FL, Feb. 06, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Melanoma Drugs Market by Therapy (Chemotherapy, Immunotherapy and Targeted Therapy) and...
February 01, 2017 08:30 ET | Source: MyoKardia, Inc.

MyoKardia Announces Appointment of June Lee, M.D., as Chief Operating Officer and Radhika Tripuraneni, M.D., as Vice President, Medical Affairs

SOUTH SAN FRANCISCO, Calif., Feb. 01, 2017 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical stage biopharmaceutical company pioneering a precision medicine approach for the treatment of...